DRREDDY Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > drreddy

Technical Analysis

Technical Strength: 7.6 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 61.9033965182. According to RSI analysis, drreddy is strong. 7 DRREDDY RSI Chart
MACD (?) MACD: 23.5659725173 and Signal Line: 19.5931945035. According to MACD analysis, a bullish crossover just happend and it's a positive signal. But note that MACD is already positive. 8.0 DRREDDY MACD Chart
Simple Moving Average (?) According to simple moving average analysis, drreddy is in a strong uptrend. Major support levels are 2798.137, 2755.692, 2690.546. 10 DRREDDY Simple Moving Average Chart
Exponential Moving Average (?) Price just got above it's 20-day exponential moving average which is a positive signal. According to exponential moving average analysis, drreddy is in a strong uptrend. Major support levels are 2784.855, 2743.582, 2661.465. 9.0 DRREDDY Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.877. According to bollinger bands, drreddy is technically strong. 7.0 DRREDDY Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 2770.1475 and 2733.125. Resistance level is 2890.0. 6.5 DRREDDY Fibonacci Retracement Chart
Average True Range (?) ATR: 61.6 NA DRREDDY Average True Range Chart
Average Directional Index (?) ADX is 22.1 which means DRREDDY is in a trading range and there is no trend. NA DRREDDY Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
November 22, 2019
Open Price 2855.0
High Price 2904.75
Low Price 2843.0
Close Price 2871.25
Absolute Change -8.0
Percentage Change -0.278%
Weekly Change 5.02%
Monthly Change 1.58%
Yearly Change 19.6%
52-week high 2964.0
52-week low 1872.95
Corporate Actions
ExDate Purpose
July 15, 2019 AGM/DIV-RS 20 PER SH
July 16, 2018 AGM/DIV-RS 20 PER SHARE
July 17, 2017 Annual General Meeting/Dividend - Rs 20/- Per Share
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.488
Confidence in Beta1.32%
Market Capital Rs. 48920.0 Cr
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 21 November 2019: Deliverable Quantity:4.55e+05 NA DRREDDY Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 21 November 2019: Daily Volatility:0.2675 NA DRREDDY Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 21 November 2019: PCR_OI:0.466 PCR:0.296 NA DRREDDY PCR Chart
Option Pain (?) 21 November 2019: Max Pain:2850.0 NA DRREDDY Option Pain Chart
Premium (?) 21 November 2019 Premium: -2.2 Futures OI:3186000.0 NA DRREDDY Premium Chart
Option_MAX_OI (?) 21 November 2019: Price:2879.25 Put with maximum OI:2800.0 Call with maximum OI:2900.0 NA DRREDDY Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
November 28, 2019 2868.55 3057750.0 3360.0 3360.0 2871.25
December 26, 2019 2880.3 354500.0 492.0 492.0 2871.25
January 30, 2020 2890.9 2500.0 3.0 3.0 2871.25


May 15, 2019 News Clarification DRREDDY: The Exchange had sought clarification from the Company with respect to news item captioned- titled "Pharma stocks bleed as US states file lawsuit against generic drug firms". In this regard, you are advised to provide clarification/confirmation on the news item in detail including the following: a) Whether such event stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order. b) The material impact of this article on the Company. c) Whether company was aware of any information that has not been announced to the Exchanges under Regulation 30 of Listing Regulations. If so, you are advised to provide the said information and the reasons for not disclosing the same to the Exchange earlier as required under Regulation 30 of the Listing Regulations. The response from the Company is attached.
October 23, 2018 Reply to Clarification Sought DRREDDY:The Exchange had sought clarification from Dr. Reddy's Laboratories Limited with respect to announcement dated 15-Oct-2018, regarding regarding a press release dated October 15, 2018, titled "Dr. Reddy's Laboratories announces the sale of its API manufacturing business unit in Jeedimetla, Hyderabad ".". On basis of above the Company is required to clarify following: 1. Additionally, in case of a slump sale, indicative disclosures provided for amalgamation/merger, shall be disclosed by the listed entity with respect to such slump sale.
See all Announcements

Board Meetings

Date Meeting Date Purpose
September 24, 2019 November 01, 2019 Financial Results To consider and approve the unaudited financial results for the period ended September 30, 2019
June 27, 2019 July 29, 2019 Financial Results To consider and approve the financial results for the period ended Jun 30, 2019
See all Board Meetings

DRREDDY is part of...

Index Weightage

Get Clearnifty's Android App.

Get clearnifty on Google Play
Get clearnifty on Google Play